Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / ADR
-
Total 13F shares
-
265,853,722
-
Share change
-
+189,930
-
Total reported value
-
$14,193,283,291
-
Put/Call ratio
-
49%
-
Price per share
-
$53.39
-
Number of holders
-
674
-
Value change
-
+$10,119,325
-
Number of buys
-
6
-
Number of sells
-
11
Institutional Holders of GLAXOSMITHKLINE PLC - ADR (GSK) as of Q4 2013
As of 31 Dec 2013,
GLAXOSMITHKLINE PLC - ADR (GSK) was held by
674 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
265,853,722 shares.
The largest 10 holders included
Dodge & Cox, ROYAL BANK OF CANADA, Fisher Asset Management, LLC, State Street Corp, PRIMECAP MANAGEMENT CO/CA/, BANK OF AMERICA CORP /DE/, PRICE T ROWE ASSOCIATES INC /MD/, WELLS FARGO & COMPANY/MN, Bank of New York Mellon Corp, and FMR LLC.
This page lists
674
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.